WHO ICTRP trial

Evaluating a multi-component drug and school and community based health and…

ACTRN12626000012370 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Not Recruiting

Key facts

Trial ID ACTRN12626000012370
Public title Evaluating a multi-component drug and school and community based health and sanitation interventions for elimination of Schistosoma mekongi in endemic communities in Cambodia and Lao PDR
Scientific title Effectiveness of a multi-component drug, water, sanitation and hygiene (WASH), and health intervention in reducing Schistosoma mekongi infection and transmission in humans and animals among endemic communities in Cambodia and Lao PDR
Primary sponsor QIMR Berghofer
Secondary sponsors Niigata University;National Centre for Parasitology, Entomology and Malaria Control;Lao Tropical and Public Health Institute
Registry Australian New Zealand Clinical Trials Registry (ANZCTR)
Recruitment status Not Recruiting
Study type Interventional
Phase Not Applicable
Countries Cambodia;Lao People's Democratic Republic
Conditions Schistosomiasis; Schistosomiasis;Infection - Other infectious diseases;Public Health - Health promotion/education;Public Health - Epidemiology
Interventions Baseline pre intervention followed by a 12 month follow-up to assess impact of the intervention. Mass drug administration (MDA) All consented individuals will be treated with a single dose of praziquantel (PZQ) (40 mg/kg) orally via tablet…
Registration date Jun 1, 2026
Target size 4000
Registry page anzctr.org.au

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations